Advertisement
Screener

REPLIGEN CORP (RGEN) Income Tax Expense

3.0 / 5 stars · 72/120 Roast Me

REPLIGEN CORP Income Tax Expense

REPLIGEN CORP (RGEN) reported Income Tax Expense of $9.14 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.

Financial Statements › Expense Statement › Income Tax

us-gaap:IncomeTaxExpenseBenefit · last filed 2026-07-29

  • REPLIGEN CORP income tax expense (benefit) for the quarter ending 2026-06-30 was $9.14M, a 173.07% increase year-over-year.
  • REPLIGEN CORP income tax expense (benefit) for the quarter ending 2026-03-31 was -$6.56M, a 410.51% decline year-over-year.
  • REPLIGEN CORP income tax expense (benefit) for the quarter ending 2025-12-31 was $5.83M.
  • REPLIGEN CORP income tax expense (benefit) for the quarter ending 2025-09-30 was $2.20M.
  • REPLIGEN CORP income tax expense (benefit) for fiscal 2025 was $13.49M.
  • REPLIGEN CORP income tax expense (benefit) for fiscal 2024 was -$1.52M, a 107.20% decline from fiscal 2023.
  • REPLIGEN CORP income tax expense (benefit) for fiscal 2023 was $21.11M, a 36.38% decline from fiscal 2022.
  • REPLIGEN CORP income tax expense (benefit) for fiscal 2022 was $33.18M, a 31.40% increase from fiscal 2021.
Period endIncome Tax Expense (Benefit) 3 monthIncome Tax Expense (Benefit) 3 month as first filedIncome Tax Expense (Benefit) 6 monthIncome Tax Expense (Benefit) 6 month as first filedIncome Tax Expense (Benefit) 9 monthIncome Tax Expense (Benefit) 9 month as first filedIncome Tax Expense (Benefit) 12 monthIncome Tax Expense (Benefit) 12 month as first filed
2026-06-30$9.14M
10-Q · filed 2026-07-29
$2.58M
10-Q · filed 2026-07-29
$8.41M
derived: sum of 3 quarters · filed 2026-07-29
$10.61M
derived: sum of 4 quarters · filed 2026-07-29
2026-03-31-$6.56M
10-Q · filed 2026-05-06
-$735.00K
derived: sum of 2 quarters · filed 2026-05-06
$1.47M
derived: sum of 3 quarters · filed 2026-05-06
$4.82M
derived: sum of 4 quarters · filed 2026-07-29
2025-12-31$5.83M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$8.03M
derived: sum of 2 quarters · filed 2026-02-26
$11.38M
derived: sum of 3 quarters · filed 2026-07-29
$13.49M
10-K · filed 2026-02-26
2025-09-30$2.20M
10-Q · filed 2025-11-04
$5.55M
derived: sum of 2 quarters · filed 2026-07-29
$7.66M
10-Q · filed 2025-11-04
$2.92M
derived: sum of 4 quarters · filed 2026-07-29
2025-06-30$3.35M
10-Q · filed 2026-07-29
$5.46M
10-Q · filed 2026-07-29
$723.00K
derived: sum of 3 quarters · filed 2026-07-29
$228.00K
derived: sum of 4 quarters · filed 2026-07-29
2025-03-31$2.11M
10-Q · filed 2026-05-06
-$2.63M
derived: sum of 2 quarters · filed 2026-05-06
-$3.12M
derived: sum of 3 quarters · filed 2026-05-06
$193.00K
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31-$4.74M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$5.23M
derived: sum of 2 quarters · filed 2026-02-26
-$1.92M
derived: sum of 3 quarters · filed 2026-02-26
-$1.52M
10-K · filed 2026-02-26
2024-09-30-$495.00K
10-Q · filed 2025-11-04
$2.82M
derived: sum of 2 quarters · filed 2025-11-04
$3.22M
10-Q · filed 2025-11-04
$21.53M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$3.31M
10-Q · filed 2025-08-07
$1.86M
10-Q · filed 2024-07-30
$3.71M
10-Q · filed 2025-08-07
$1.88M
10-Q · filed 2024-07-30
$22.03M
derived: sum of 3 quarters · filed 2026-02-26
$16.49M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$399.00K
10-Q · filed 2025-04-29
$20.00K
10-Q · filed 2024-05-01
$18.71M
derived: sum of 2 quarters · filed 2026-02-26
$13.17M
derived: sum of 3 quarters · filed 2026-02-26
$18.29M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$18.32M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-02-26
$12.77M
derived: sum of 2 quarters · filed 2026-02-26
$17.89M
derived: sum of 3 quarters · filed 2026-02-26
$21.11M
10-K · filed 2026-02-26
$22.55M
10-K · filed 2024-02-22
2023-09-30-$5.54M
10-Q/A · filed 2024-11-18
-$6.54M
10-Q · filed 2023-10-31
-$423.00K
derived: sum of 2 quarters · filed 2024-11-18
$2.80M
10-Q/A · filed 2024-11-18
$5.82M
10-Q · filed 2023-10-31
$7.05M
derived: sum of 4 quarters · filed 2025-03-14
2023-06-30$5.12M
10-Q/A · filed 2024-11-18
$5.10M
10-Q · filed 2023-08-02
$8.34M
10-Q/A · filed 2024-11-18
$12.36M
10-Q · filed 2023-08-02
$12.60M
derived: sum of 3 quarters · filed 2025-03-14
$19.66M
derived: sum of 4 quarters · filed 2025-03-14
2023-03-31$3.22M
10-Q/A · filed 2024-11-18
$7.26M
10-Q · filed 2023-05-02
$7.48M
derived: sum of 2 quarters · filed 2025-03-14
$14.54M
derived: sum of 3 quarters · filed 2025-03-14
$24.43M
derived: sum of 4 quarters · filed 2025-03-14
2022-12-31$4.26M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-03-14
$11.32M
derived: sum of 2 quarters · filed 2025-03-14
$21.21M
derived: sum of 3 quarters · filed 2025-03-14
$33.18M
10-K · filed 2025-03-14
2022-09-30$7.06M
10-Q/A · filed 2024-11-18
$16.96M
derived: sum of 2 quarters · filed 2024-11-18
$28.92M
10-Q/A · filed 2024-11-18
$34.66M
derived: sum of 4 quarters · filed 2024-11-18
2022-06-30$9.89M
10-Q/A · filed 2024-11-18
$21.86M
10-Q/A · filed 2024-11-18
$27.60M
derived: sum of 3 quarters · filed 2024-11-18
$35.33M
derived: sum of 4 quarters · filed 2024-11-18
2022-03-31$11.97M
10-Q/A · filed 2024-11-18
$17.70M
derived: sum of 2 quarters · filed 2024-11-18
$25.44M
derived: sum of 3 quarters · filed 2024-11-18
$33.56M
derived: sum of 4 quarters · filed 2024-11-18
2021-12-31$5.74M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-18
$13.47M
derived: sum of 2 quarters · filed 2024-11-18
$21.60M
derived: sum of 3 quarters · filed 2024-11-18
$25.25M
10-K/A · filed 2024-11-18
2021-09-30$7.73M
10-Q · filed 2022-11-01
$15.86M
derived: sum of 2 quarters · filed 2022-11-01
$19.51M
10-Q · filed 2022-11-01
$14.59M
derived: sum of 4 quarters · filed 2023-02-22
2021-06-30$8.13M
10-Q · filed 2022-08-02
$11.78M
10-Q · filed 2022-08-02
$6.86M
derived: sum of 3 quarters · filed 2023-02-22
$10.05M
derived: sum of 4 quarters · filed 2023-02-22
2021-03-31$3.65M
10-Q · filed 2022-04-27
-$1.26M
derived: sum of 2 quarters · filed 2023-02-22
$1.93M
derived: sum of 3 quarters · filed 2023-02-22
$2.08M
derived: sum of 4 quarters · filed 2023-02-22
2020-12-31-$4.92M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22
-$1.73M
derived: sum of 2 quarters · filed 2023-02-22
-$1.57M
derived: sum of 3 quarters · filed 2023-02-22
-$709.00K
10-K · filed 2023-02-22
2020-09-30$3.19M
10-Q · filed 2021-10-28
$3.35M
derived: sum of 2 quarters · filed 2021-10-28
$4.21M
10-Q · filed 2021-10-28
$4.95M
derived: sum of 4 quarters · filed 2022-02-17
2020-06-30$159.00K
10-Q · filed 2021-07-27
$1.02M
10-Q · filed 2021-07-27
$1.76M
derived: sum of 3 quarters · filed 2022-02-17
$1.77M
derived: sum of 4 quarters · filed 2022-02-17
2020-03-31$861.00K
10-Q · filed 2021-05-04
$1.60M
derived: sum of 2 quarters · filed 2022-02-17
$1.61M
derived: sum of 3 quarters · filed 2022-02-17
$3.14M
derived: sum of 4 quarters · filed 2022-02-17
2019-12-31$741.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17
$753.00K
derived: sum of 2 quarters · filed 2022-02-17
$2.28M
derived: sum of 3 quarters · filed 2022-02-17
$4.74M
10-K · filed 2022-02-17
2019-09-30$12.00K
10-Q · filed 2020-11-05
$1.54M
derived: sum of 2 quarters · filed 2020-11-05
$4.00M
10-Q · filed 2020-11-05
$5.23M
derived: sum of 4 quarters · filed 2021-02-24
2019-06-30$1.52M
10-Q · filed 2020-07-30
$3.99M
10-Q · filed 2020-07-30
$5.22M
derived: sum of 3 quarters · filed 2021-02-24
$7.05M
derived: sum of 4 quarters · filed 2021-02-24
2019-03-31$2.46M
10-Q · filed 2020-05-06
$3.70M
derived: sum of 2 quarters · filed 2021-02-24
$5.53M
derived: sum of 3 quarters · filed 2021-02-24
$6.15M
derived: sum of 4 quarters · filed 2021-02-24
2018-12-31$1.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
$3.06M
derived: sum of 2 quarters · filed 2021-02-24
$3.69M
derived: sum of 3 quarters · filed 2021-02-24
$4.82M
10-K · filed 2021-02-24
2018-09-30$1.83M
10-Q · filed 2019-10-31
$2.46M
derived: sum of 2 quarters · filed 2019-10-31
$3.59M
10-Q · filed 2019-10-31
-$7.04M
derived: sum of 4 quarters · filed 2019-10-31
2018-06-30$629.00K
10-Q · filed 2019-08-01
$1.76M
10-Q · filed 2019-08-01
-$8.87M
derived: sum of 3 quarters · filed 2019-08-01
-$15.56M
derived: sum of 4 quarters · filed 2019-08-01
2018-03-31$1.13M
10-Q · filed 2019-05-09
-$9.50M
derived: sum of 2 quarters · filed 2019-05-09
-$16.19M
derived: sum of 3 quarters · filed 2019-05-09
-$20.98M
derived: sum of 4 quarters · filed 2019-05-09
2017-12-31-$10.63M
10-K · filed 2018-02-22
-$17.32M
derived: sum of 2 quarters · filed 2018-11-01
-$22.10M
derived: sum of 3 quarters · filed 2018-11-01
-$21.11M
10-K · filed 2020-02-26
2017-09-30-$6.69M
10-Q · filed 2018-11-01
-$11.47M
derived: sum of 2 quarters · filed 2018-11-01
-$10.48M
10-Q · filed 2018-11-01
-$13.94M
derived: sum of 4 quarters · filed 2018-11-01
2017-06-30-$4.78M
10-Q · filed 2018-08-02
-$3.79M
10-Q · filed 2018-08-02
-$7.25M
derived: sum of 3 quarters · filed 2018-08-02
-$6.19M
derived: sum of 4 quarters · filed 2018-08-02
2017-03-31$999.00K
10-Q · filed 2018-05-08
-$2.46M
derived: sum of 2 quarters · filed 2018-05-08
-$1.41M
derived: sum of 3 quarters · filed 2018-05-08
$95.00K
derived: sum of 4 quarters · filed 2018-05-08
2016-12-31-$3.46M
10-K · filed 2018-02-22
$3.46M
10-K · filed 2017-02-23
-$2.40M
derived: sum of 2 quarters · filed 2018-02-22
-$904.00K
derived: sum of 3 quarters · filed 2018-02-22
$11.00K
10-K · filed 2019-03-01
2016-09-30$1.06M
10-K · filed 2018-02-22
$2.56M
derived: sum of 2 quarters · filed 2018-02-22
$3.47M
10-Q · filed 2017-11-09
$4.40M
derived: sum of 4 quarters · filed 2018-02-22
2016-06-30$1.50M
10-Q · filed 2017-08-03
$2.42M
10-Q · filed 2017-08-03
$3.34M
derived: sum of 3 quarters · filed 2018-02-22
$4.49M
derived: sum of 4 quarters · filed 2018-02-22
2016-03-31$915.00K
10-K · filed 2018-02-22
$1.84M
derived: sum of 2 quarters · filed 2018-02-22
$2.98M
derived: sum of 3 quarters · filed 2018-02-22
$3.72M
derived: sum of 4 quarters · filed 2018-02-22
2015-12-31$929.00K
10-K · filed 2017-02-23
$2.07M
derived: sum of 2 quarters · filed 2017-02-23
$2.81M
derived: sum of 3 quarters · filed 2017-02-23
$4.08M
10-K · filed 2018-02-22
2015-09-30$1.14M
10-K · filed 2017-02-23
$1.88M
derived: sum of 2 quarters · filed 2017-02-23
$3.15M
10-Q · filed 2016-11-03
$3.79M
derived: sum of 4 quarters · filed 2017-02-23
2015-06-30$738.00K
10-K · filed 2017-02-23
$738.83K
10-Q · filed 2015-08-06
$2.01M
10-Q · filed 2016-08-04
$2.01M
10-Q · filed 2015-08-06
$2.65M
derived: sum of 3 quarters · filed 2017-02-23
$3.44M
derived: sum of 4 quarters · filed 2017-02-23
2015-03-31$1.27M
10-K · filed 2017-02-23
$1.27M
10-Q · filed 2015-05-08
$1.91M
derived: sum of 2 quarters · filed 2017-02-23
$2.70M
derived: sum of 3 quarters · filed 2017-02-23
$3.12M
derived: sum of 4 quarters · filed 2017-02-23
2014-12-31$640.00K
10-K · filed 2016-02-25
$1.43M
derived: sum of 2 quarters · filed 2016-02-25
$1.85M
derived: sum of 3 quarters · filed 2016-02-25
$2.97M
10-K · filed 2017-02-23
$2.97M
10-K · filed 2015-03-17
2014-09-30$789.00K
10-K · filed 2016-02-25
$788.32K
10-Q · filed 2014-11-07
$1.21M
derived: sum of 2 quarters · filed 2016-02-25
$2.33M
10-Q · filed 2015-11-05
$2.33M
10-Q · filed 2014-11-07
$4.21M
derived: sum of 4 quarters · filed 2016-02-25
2014-06-30$418.00K
10-K · filed 2016-02-25
$417.83K
10-Q · filed 2014-08-11
$1.54M
10-Q · filed 2015-08-06
$3.43M
derived: sum of 3 quarters · filed 2016-02-25
$5.68M
derived: sum of 4 quarters · filed 2016-02-25
2014-03-31$1.12M
10-K · filed 2016-02-25
$1.12M
10-Q · filed 2014-05-09
$3.01M
derived: sum of 2 quarters · filed 2016-02-25
$5.26M
derived: sum of 3 quarters · filed 2016-02-25
$6.76M
derived: sum of 4 quarters · filed 2016-02-25
2013-12-31$1.89M
10-K · filed 2015-03-17
$4.14M
derived: sum of 2 quarters · filed 2015-03-17
$5.64M
derived: sum of 3 quarters · filed 2015-03-17
$6.92M
10-K · filed 2016-02-25
$6.92M
10-K · filed 2014-03-14
2013-09-30$2.25M
10-K · filed 2015-03-17
$2.25M
10-Q · filed 2013-11-08
$3.75M
derived: sum of 2 quarters · filed 2015-03-17
$5.03M
10-Q · filed 2014-11-07
$1.90M
derived: sum of 4 quarters · filed 2015-03-17
2013-06-30$1.50M
10-K · filed 2015-03-17
$1.49M
10-Q · filed 2013-08-07
$2.78M
10-Q · filed 2014-08-11
-$356.00K
derived: sum of 3 quarters · filed 2015-03-17
-$372.00K
derived: sum of 4 quarters · filed 2015-03-17
2013-03-31$1.28M
10-K · filed 2015-03-17
$1.28M
10-Q · filed 2013-05-07
-$1.85M
derived: sum of 2 quarters · filed 2015-03-17
-$1.87M
derived: sum of 3 quarters · filed 2015-03-17
-$1.66M
derived: sum of 4 quarters · filed 2015-03-17
2012-12-31-$3.13M
10-K · filed 2014-03-14
-$3.15M
derived: sum of 2 quarters · filed 2014-03-14
-$2.94M
derived: sum of 3 quarters · filed 2014-03-14
-$2.88M
10-K · filed 2015-03-17
2012-09-30-$16.00K
10-K · filed 2014-03-14
-$16.18K
10-Q · filed 2012-11-08
$192.00K
derived: sum of 2 quarters · filed 2014-03-14
$250.95K
10-Q · filed 2013-11-08
$267.00K
derived: sum of 4 quarters · filed 2014-03-14
2012-06-30$208.00K
10-K · filed 2014-03-14
$208.23K
10-Q · filed 2012-08-09
$267.14K
10-Q · filed 2013-08-07
$283.00K
derived: sum of 3 quarters · filed 2014-03-14
2012-03-31$59.00K
10-K · filed 2014-03-14
$58.91K
10-Q · filed 2012-05-10
$75.00K
derived: sum of 2 quarters · filed 2014-03-14
2011-12-31$16.00K
10-K · filed 2013-03-15
$15.74K
10-K · filed 2014-03-14
$15.77K
10-K · filed 2013-03-15
2010-03-31-$834.77K
10-K · filed 2012-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
BIO-TECHNE Corp (TECH)United States$11.379B74.68
Twist Bioscience Corp (TWST)United States$11.540B-47.21
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
EXELIXIS, INC. (EXEL)United States$14.358B16.15
Immunovant, Inc. (IMVT)United States$7.028B-14.78